Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).
The appearance of activated immune cells and the accumulation of inflammation-associated proteins are common phenomena associated with neurodegenerative diseases. These inflammatory components of central nervous system (CNS) diseases have most often been described in the context of an immune response to damage and cell loss already occurring in the affected brain area. There has, however, been a renewed interest in how the neuroimmune axis might itself be involved in the etiology of these neurodegenerative diseases, particularly in cases involving slow, chronic, progressive neuropathology. This review addresses immune activation in Alzheimer's, Parkinson's, and brain viral infections that may be causative of, rather than responsive to, the observed neuronal loss in these pathologies.
Ringheim
Garth E
GE
Immunology Platform, Aventis Pharmaceuticals, Inc., Route 202-206, Mail Stop G303A, Bridgewater, NJ 08807-0800, USA. garth.ringheim@aventis.com
Conant
Katherine
K
D000544:Alzheimer Disease / Q000276:immunology; D006801:Humans; D019636:Neurodegenerative Diseases / Q000276:immunology* / Q000503:physiopathology; D015213:Neuroimmunomodulation; D010300:Parkinson Disease / Q000276:immunology; D014777:Virus Diseases / Q000276:immunology